Hygea, set up in 2010 in Beijing, specialises in leveraging micro-invasive and cryo-hit technology that is used for cryogenic destruction of tissue during surgical procedures. Its devices primarily cater to therapies targeted at cancers of the lung, liver, breasts, and kidney. Hygea has partnered with nearly 100 portfolio medical institutes in China, including Beijing Cancer Hospital, Fudan University Shanghai Cancer Center, and Cancer Hospital Chinese Academy of Medical Science.
Member count: 11-50
Founded date: 2010
Investors 1
| Date | Name | Website |
| - | Grand Flig... | gfinvestme... |